Liposomal Enhancement of the Antitumor Activity of Conditionally Replication-Competent Adenoviral Plasmids
Open Access
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (4) , 489-495
- https://doi.org/10.1016/j.ymthe.2004.01.018
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy VectorsJournal of Clinical Microbiology, 2003
- Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy, 2002
- Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian CancerJournal of Clinical Oncology, 2002
- Transfection of large plasmids in primary human myoblastsGene Therapy, 2001
- ONYX-015 selectivity and the p14ARF pathwayOncogene, 2000
- Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 statusGene Therapy, 2000
- A blood–tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compoundsGene Therapy, 2000
- Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cellsGene Therapy, 1997
- Adenovirus-Mediated Gene Transfer of Herpes Simplex Virus Thymidine Kinase in an Ascites Model of Human Breast CancerHuman Gene Therapy, 1996
- Covalently closed circles of adenovirus 5 DNANature, 1983